Singapore markets open in 3 hours 20 minutes

Vaxart, Inc. (VXRT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.1600+0.0900 (+2.21%)
At close: 04:00PM EDT
4.0800 -0.08 (-1.92%)
After hours: 07:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close4.0700
Bid4.0700 x 3200
Ask4.1600 x 27000
Day's range4.0150 - 4.1650
52-week range2.4900 - 9.5000
Avg. volume2,699,856
Market cap526.265M
Beta (5Y monthly)0.69
PE ratio (TTM)N/A
EPS (TTM)-0.6410
Earnings date02 Nov 2022 - 07 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend date09 Nov 2012
1y target est8.50
  • Zacks

    VAXART, INC. (VXRT) Reports Q2 Loss, Lags Revenue Estimates

    VAXART, INC. (VXRT) delivered earnings and revenue surprises of -9.52% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Motley Fool

    Could This Unknown Stock Beat Moderna in 2023?

    Vaxart (NASDAQ: VXRT) might just be gearing up to steal coronavirus vaccine market share from Moderna (NASDAQ: MRNA) in the next couple of years, making its investors wealthy in the process. The biotech's vaccine tablets could have a few advantages that Moderna's shots don't, including one in particular, that might be a public health holy grail at the moment. For Vaxart's stock to beat Moderna's next year, two things need to happen.

  • Motley Fool

    3 Revolutionary Stocks I'd Buy Right Now Without Hesitation

    Vaxart (NASDAQ: VXRT) is working on a coronavirus vaccine candidate. Recently, Vaxart said its omicron-specific candidate and its original candidate both protected against the variant in preclinical tests. Of course, even if Vaxart is successful, the company will make it to market much later than bigger rivals.